This article provides a case report of a patient with pedophilia who was treated over a 4-year period with medroxyprogesterone acetate (MPA) at a dose of 300 mg/day and as a consequence developed Cushing's Syndrome and adrenal insufficiency, for which he was treated and from which he recovered. He also reported a hypersexual reaction to his own past cessation of MPA. Gonadotropin-releasing hormone agonists, which have a more benign side-effect profile than MPA, are suggested as an alternative to MPA.
Dux, S., Bishara, J., Marom, D., Blum, I., & Pitlik, S. (1998). Medroxyprogesterone acetate-induced secondary adrenal insufficiency. Annals of Pharmacotherapy, 32, 134.
2.
Malik, K.J., Wakelin, K., Dean, S., Cove, D.H., & Wood, P.J. (1996). Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate. Annals of Clinical Biochemistry, 33, 187-189.
3.
Rosler, A., & Witztum, E. (2000). Pharmacotherapy of paraphilias in the next millennium . Behavioral Sciences and the Law, 18, 43-56.
4.
Sadeghi-Nejad, A., Kaplan, S.L., & Grumbach, M.M. (1971). The effect of medroxyprogesterone acetate on adrenocortical function in children with precocious puberty. Journal of Pediatrics, 78, 616-624.
5.
Stein, D.J., Black, D.W., Shapira, N.A., & Spitzer, R.L. (2001). Hypersexual disorder and preoccupation with Internet pornography. American Journal of Psychiatry, 158,1590-1594.
